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Abstract. 
 
Pleckstrin is a 40-kD phosphoprotein con-
 
taining NH
 
2
 
- and COOH-terminal pleckstrin homology
(PH) domains separated by a disheveled-egl 10-pleck-
strin (DEP) domain. After platelet activation, pleckstrin
is rapidly phosphorylated by protein kinase C. We re-
ported previously that expressed phosphorylated pleck-
strin induces cytoskeletal reorganization and localizes
in microvilli along with glycoproteins, such as integrins.
Given the role of integrins in cytoskeletal organization
and cell spreading, we investigated whether signaling
from pleckstrin cooperated with signaling pathways in-
 
volving the platelet integrin, 
 
a
 
IIb
 
b
 
3. Pleckstrin induced
cell spreading in both transformed (COS-1 & CHO)
 
and nontransformed (REF52) cell lines, and this spread-
ing was regulated by pleckstrin phosphorylation. In
REF52 cells, pleckstrin-induced spreading was matrix
dependent, as evidenced by spreading of these cells on
ﬁbrinogen but not on ﬁbronectin. Coexpression with
 
a
 
IIb
 
b
 
3 did not enhance pleckstrin-mediated cell spread-
ing in either REF52 or CHO cells. However, coexpres-
 
sion of the inactive variant 
 
a
 
IIb
 
b
 
3 Ser753Pro, or 
 
b
 
3
Ser753Pro alone, completely blocked pleckstrin-induced
spreading. This implies that 
 
a
 
IIb
 
b
 
3 Ser753Pro functions
as a competitive inhibitor by blocking the effects of an
endogenous receptor that is used in the signaling path-
way involved in pleckstrin-induced cell spreading. Ex-
pression of a chimeric protein composed of the extra-
cellular and transmembrane portion of Tac fused to the
cytoplasmic tail of 
 
b
 
3 completely blocked pleckstrin-
mediated spreading, whereas chimeras containing the
cytoplasmic tail of 
 
b
 
3 Ser753Pro or 
 
a
 
IIb had no effect.
This suggests that the association of an unknown signal-
ing protein with the cytoplasmic tail of an endogenous
integrin 
 
b
 
-chain is also required for pleckstrin-induced
spreading. Thus, expressed phosphorylated pleckstrin
promotes cell spreading that is both matrix and integrin
dependent. To our knowledge, this is the ﬁrst example
of a mutated integrin functioning as a dominant nega-
tive inhibitor.
Key words: pleckstrin • integrins • platelets • cell
spreading • PH domain
 
Introduction
 
Phosphorylation of pleckstrin, a 40–47-kD protein present
in platelets and leukocytes, is one of the earliest detectable
events after platelet stimulation (Haslam et al., 1979). The
350-amino acid pleckstrin sequence can be divided into
three motifs: pleckstrin homology (PH)
 
1
 
 domains at the
NH
 
2 
 
and COOH termini of the molecule, and an interven-
ing disheveled-egl 10-pleckstrin (DEP) domain (Tyers et
al., 1988; Ponting and Bork, 1996). Pleckstrin homology
(PH) domains have been identified in 
 
z
 
130 other pro-
teins, and likely constitute phosphoinositide-binding mo-
tifs (Lemmon et al., 1996), whereas the function of DEP
domains is uncertain. A short stretch of amino acids be-
tween the NH
 
2
 
-terminal PH domain and the DEP domain
contains three oxygenated residues (Ser
 
113
 
, Thr
 
114
 
, and
Ser
 
117
 
) that are phosphorylated by protein kinase C (PKC)
and are essential for pleckstrin’s function (Abrams et al.,
1995, 1996; Ma et al., 1997).
 
When overexpressed in tissue culture cells, pleckstrin in-
duces the formation of, and localizes within, lamellipodia,
ruffles, and microvilli. Coincident with the formation of these
structures is dissolution of central actin fibers and the forma-
tion of cortical actin cables (Ma and Abrams, 1999). Pleck-
strin-induced ruffles and microvilli also appear to be sites of
high local concentrations of membrane glycoproteins (Ma et
al., 1997). These membrane and actin changes require pleck-
strin phosphorylation and the presence of the pleckstrin
 
NH
 
2
 
-terminal, but not the COOH-terminal, PH domain.
Integrins are a ubiquitous family of adhesion receptors
that mediate cell–cell and cell–matrix interactions in pro-
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cesses as diverse as embryogenesis, metastasis, host de-
fense, hemostasis, and wound repair. In platelets, the inte-
grin 
 
a
 
IIb
 
b
 
3 is required for platelet aggregation (Bennett
et al., 1983). After platelet stimulation by agonists such as
thrombin or ADP, the resulting “inside-out” signaling in-
duces a conformational change in 
 
a
 
IIb
 
b
 
3 that is associated
with an increased affinity for the ligands fibrinogen and
von Willebrand factor (Shattil, 1999). In turn, ligand bind-
ing to 
 
a
 
IIb
 
b
 
3 initiates “outside-in” signaling, character-
ized by activation of protein and lipid kinases and, ulti-
mately, remodeling of the platelet’s actin cytoskeleton.
Although pleckstrin and 
 
a
 
IIb
 
b
 
3 each play a role in
platelet cytoskeletal reorganization, a direct connection
between the cytoskeletal effects of each protein has not
been identified. In this report, we demonstrate that pleck-
strin overexpression induces the spreading of a number of
transformed and nontransformed cell lines. Furthermore,
we demonstrate that this effect of pleckstrin is matrix spe-
cific and can be regulated by pleckstrin phosphorylation
and by the 
 
b
 
 subunit of 
 
a
 
IIb
 
b
 
3.
 
Materials and Methods
 
Tissue Culture and Reagents
 
REF52 and COS-1 cells were maintained in DME supplemented with
 
L
 
-glutamine, penicillin/streptomycin, and 10% FBS. CHO cells were
maintained in F-12 Nutrient Mixture (HAM) supplemented with 
 
L
 
-glu-
tamine, penicillin/streptomycin, and 10% FBS. In selected experiments, fi-
brinogen (Calbiochem-Novabiochem) or fibronectin (Sigma-Aldrich)
were applied to chamber slides according to the manufacturer’s instruc-
tion. The cDNA encoding 
 
a
 
IIb, 
 
b
 
3, or 
 
b
 
3 Ser753Pro were inserted into
pcDNA3.1
 
1
 
. Plasmids directing the expression of hemagglutinin antigen
(HA) epitope–tagged wild-type pleckstrin, as well as pseudo-phosphory-
lated (3 Glu) and nonphosphorylatable (3 Gly) variants of pleckstrin,
were generated by subcloning HindIII–BamHI fragments of previously
described plasmids into pcDNA3.1
 
1
 
 (Ma et al., 1997). The CMV-IL2R
plasmids directing the expression of Tac-
 
a
 
IIb, Tac-
 
b
 
3, and Tac-
 
b
 
3 S752P
were a gift from Dr. Timothy O’Toole (Scripps Research Institute, La
Jolla, CA) and have been described previously (Chen et al., 1994a).
 
Heterologous Expression of Pleckstrin, Pleckstrin 
Mutants, and 
 
a
 
IIb
 
b
 
3
 
Pleckstrin, pleckstrin mutants, and 
 
a
 
IIb
 
b
 
3 were expressed transiently in
COS-1 or CHO cells. In brief, cells were cultured on 100-mm polystyrene
tissue culture dishes (Falcon) and transfected with plasmid DNA by cal-
cium phosphate coprecipitation or Lipofectamine (Life Technologies) 24 h
after transfection, cells were shocked with 10% glycerol, treated with
trypsin, and replated onto 2-well chamber slides (Falcon). After an addi-
tional 24 h incubation, the cells were fixed using 3% neutral buffered for-
malin and stained with fluorescent antibodies.
REF52 cells were plated onto gridded fibronectin or fibrinogen coated
coverslips (Bellco Glass) at 60% confluency. To prepare quiescent cells
for microinjection, the cells were incubated in medium containing 0.1%
FBS for 36 h. The cells were then microinjected with plasmid DNA in mi-
croinjection buffer (100 mM Hepes, pH 7.2; 200 mM KCl; 10 mM NaPO
 
4
 
,
pH 7.2) according to the following protocol: (i) 
 
a
 
IIb (12.5 ng/
 
m
 
l) -
 
b
 
3
(12.5 ng/
 
m
 
l) and pcDNA3.1
 
1
 
 (vector; 25 ng/
 
m
 
l); (ii) pseudo-phosphory-
lated pleckstrin (25 ng/
 
m
 
l) and 
 
a
 
IIb (12.5 ng/
 
m
 
l) -
 
b
 
3 (12.5 ng/
 
m
 
l); (iii)
pseudo-phosphorylated pleckstrin (25 ng/
 
m
 
l) and pcDNA3.1
 
1
 
 (vector; 25
ng/
 
m
 
l). In selected experiments, 
 
b
 
3 Ser753Pro was substituted for the
wild-type 
 
b
 
3. Microinjection was performed using Eppendorf Transjector
5246 (P
 
2
 
 5 
 
80, P
 
3
 
 5 
 
30, injection time 
 
5 
 
0.3 s). Unless otherwise indicated,
cells were fixed 4 h after injection in 3% neutral buffered formalin.
 
Immunofluorescence and Quantitation of
Cell Spreading
 
Cells were stained for proteins of interest using the appropriate primary
 
antibody, and counterstained with a fluorescent secondary antibody as
previously described (Ma et al., 1997). Proteins coupled to the fluorescent
antibodies were visualized using a Nikon Microphot-SA microscope. Im-
ages were captured using IPLab Spectrum Image Analysis software for
the Macintosh and a Photometrics SenSys KF1400 camera (BioVi-
sion Technologies). For each experiment, quantitation of footprint size of
20–50 cells was performed. All results shown represent the mean 
 
6 
 
SEM
of at least three independent experiments.
 
Results
 
Overexpression of Phosphorylated Pleckstrin Produces 
Cell Spreading
 
Having previously determined that pleckstrin overexpres-
sion alters cytoskeletal organization in various tissue cul-
ture cells (Ma and Abrams, 1999), we addressed whether
pleckstrin overexpression also affects cell spreading. We
transiently expressed wild-type pleckstrin in COS-1 cells
and examined the morphology of cells adherent to the
wells of tissue culture plates. Pleckstrin-induced actin re-
organization is regulated by pleckstrin’s phosphorylation
state (Ma and Abrams, 1999), and it is noteworthy that
wild-type pleckstrin is maximally phosphorylated when
overexpressed in COS-1 cells, even in the absence of ago-
nists or serum (Ma et al., 1997). As shown in Fig. 1, cells
expressing wild-type pleckstrin appeared larger and more
spread than mock-transfected cells or cells expressing
green fluorescent protein (GFP). Quantification of cell
size revealed that COS-1 cells expressing wild-type pleck-
strin were 
 
z
 
65% larger than control cells. The difference
in cell size was reproducible and statistically significant
(
 
P
 
 , 
 
0.0001). Similar effects were also found when pleck-
strin was expressed in CHO cells (data not shown). More-
over, the pleckstrin-induced increase in footprint size was
larger than that induced by constitutively active Rac L61, a
potent activator of cell spreading (
 
P
 
 , 
 
0.0001; Nobes and
Hall, 1995; D’Souza-Schorey et al., 1998; Price et al.,
1998).
Substitution of phosphorylated Ser
 
113
 
, Thr
 
114
 
, and Ser
 
117
 
by glycine (nonphosphorylatable pleckstrin) inhibits pleck-
strin function (Abrams et al., 1996), whereas replacement
of these residues with negatively-charged glutamates
(pseudo-phosphorylation) induces both constitutive pleck-
strin biochemical activity and changes in actin organiza-
tion. To address whether pleckstrin-induced cell spreading
is regulated by pleckstrin phosphorylation, COS-1 cells
were transfected with plasmids encoding the nonphosphor-
ylatable and pseudo-phosphorylated pleckstrin mutants.
Pseudo-phosphorylated pleckstrin induced a significant in-
crease in cell footprint size compared with GFP (
 
P
 
 ,
 
0.0001), but not significantly different from wild-type
pleckstrin (
 
P
 
 5 
 
0.34). We also found that although overex-
pression of the glycine pleckstrin mutant increased the
footprint size of transfected cells compared with control
cells expressing GFP (
 
P
 
 , 
 
0.001), the increased spreading
was significantly less than that of cells expressing the
pseudo-phosphorylated mutant (
 
P
 
 , 
 
0.0001) or wild-type
pleckstrin (
 
P
 
 , 
 
0.002). These results suggest that most of
pleckstrin’s effect on cell size involves the NH
 
2
 
-terminal
PH domain which we have previously demonstrated is reg-
ulated by pleckstrin phosphorylation (Abrams et al.,
1995). However, other regions of the molecule also appear 
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to contribute. Thus, not only does pleckstrin reorganize
the cytoskeleton of transfected cells, but it also facilitates
cell spreading. In addition, pleckstrin phosphorylation, or
pseudo-phosphorylation, is required for maximal effect.
 
Effect of
 
 
 
a
 
IIb
 
b
 
3 and Fibrinogen on Pleckstrin-induced 
Cell Spreading
 
Pleckstrin and integrins colocalize in the lamellipodia of
pleckstrin-transfected COS-1 cells (Ma et al., 1997). Be-
cause 
 
a
 
IIb
 
b
 
3 is the most abundant platelet integrin and
pleckstrin is present in platelets, we asked whether pleck-
strin-induced cell spreading was affected by the presence
of 
 
a
 
IIb
 
b
 
3 or its ligand, fibrinogen. To address the effect of
 
a
 
IIb
 
b
 
3 and fibrinogen, we examined the consequences of
microinjecting cDNA that direct the expression of 
 
a
 
IIb
 
b
 
3,
pleckstrin variants, or both into adherent REF52 cells.
REF52 cells are a nontransformed cell line that can be se-
rum-starved into quiescence.
We first examined the effect of pleckstrin and 
 
a
 
IIb
 
b
 
3 on
the spreading of REF52 cells adherent to surfaces coated
with fibrinogen. As shown in Figs. 2 and 3, microinjecting
wild-type 
 
a
 
IIb
 
b
 
3 did not induce cell spreading when com-
pared with control cells microinjected with a plasmid that
directed the expression of GFP (
 
P
 
 5 
 
0.38). Similarly, mi-
croinjecting the nonphosphorylatable pleckstrin mutant
with and without 
 
a
 
IIb
 
b
 
3 had no effect on cell footprint
size (
 
P
 
 5 
 
0.79 and
 
 P 
 
5 
 
0.66, respectively). As indicated by
the quantitative analysis shown in Fig. 3, microinjection of
pseudo-phosphorylated pleckstrin significantly increased
the footprint of adherent REF52 cells compared with cells
microinjected with either 
 
a
 
IIb
 
b
 
3 or GFP (
 
P
 
 , 
 
0.002 and
 
P 
 
, 
 
0.0002, respectively). On the other hand, the effect of
microinjecting cells with pseudo-phosphorylated pleck-
strin and 
 
a
 
IIb
 
b
 
3 was no different than microinjecting cells
with pseudo-phosphorylated pleckstrin alone (
 
P
 
 5 0.32).
Time course experiments indicate that some pleckstrin ex-
pression and cell spreading is seen as soon as 30 min after
microinjection with plasmids. Pleckstrin expression and
cell spreading reached a maximum 4-6 h after microinjec-
tion. This is consistent with the time course of expression
of most proteins after microinjection of plasmids. PMA
stimulation of these cells without pleckstrin-expression in-
duces ruffling, but not spreading (data not shown). To-
gether these results imply that pleckstrin-mediated cell
spreading requires PKC; however, in these cells PKC acti-
vation alone is not sufficient to induce cell spreading.
We next compared the effect of pseudo-phosphorylated
pleckstrin and aIIbb3 on the spreading of REF52 cells on
tissue culture slides coated with fibrinogen or fibronectin.
Fibrinogen is the predominant ligand for aIIbb3, and
fibronectin is the predominant ligand for integrins such
as a5b1. As shown in Fig. 4 (and graphically in Fig. 3),
we found that pseudo-phosphorylated pleckstrin induced
REF52 cell spreading on fibrinogen-coated surfaces, but
Figure 1. Phosphorylated
pleckstrin induces cell
spreading. COS-1 cells were
transiently transfected with
plasmids that direct the ex-
pression of GFP (A), HA
epitope tagged Rac L61 (B),
HA-tagged wild-type pleck-
strin (C), HA phosphoryla-
tion–deficient pleckstrin (D),
or HA-pseudo-phosphory-
lated pleckstrin (E). Shown is
autofluorescence (A), anti-HA staining (B), and anti-HA staining (C–E) as visualized by indirect immunofluorescence. This figure
demonstrates that wild-type pleckstrin induces spreading in COS-1 cells, and this spreading is affected by mutations within the phosphor-
ylation sites. Original magnifications, 320.
Figure 2. Pleckstrin induces REF52 cells to spread on fibrinogen.
Quiescent REF52 cells plated on fibrinogen were microinjected
with plasmids that direct the expression of GFP (A), wild-type
aIIbb3 alone (B), HA phosphorylation–deficient pleckstrin
alone (C) or with wild-type aIIbb3 (D), or HA–pseudo-phos-
phorylated pleckstrin alone (E) or with wild-type aIIbb3 (F).
Cells were stained both with anti-HA, to detect pleckstrin, and
anti-b3, to detect aIIbb3. Shown is autofluorescence (A), anti-b3
staining (B), or anti-HA staining (C–F) as visualized by indirect
immunofluorescence. This figure demonstrates that in contrast to
phosphorylation-deficient pleckstrin, the pseudo-phosphorylated
variant induces REF52 cells spreading on fibrinogen. This
spreading is not influenced by expression of wild-type aIIbb3.
Original magnifications, 320.The Journal of Cell Biology, Volume 150, 2000 1464
failed to do so when the surfaces were coated with fi-
bronectin. Moreover, there was no significance difference
in footprint size of cells plated on fibronectin regardless of
whether they were expressing any combination of GFP,
pseudo-phosphorylation pleckstrin, or aIIbb3 (ANOVA,
P 5 0.11). Thus, these results indicate that not only does
pleckstrin induce cell spreading but its effect is dependent
on the substrate for cell adhesion. The data also suggest
that the pleckstrin-induced spreading of REF52 cells re-
quires the presence of an adhesion molecule that is capa-
ble of interacting with fibrinogen.
Although expressing aIIbb3 in REF52 cells does not ap-
pear to effect pleckstrin-mediated cell spreading, it is pos-
sible that aIIbb3 had no effect because endogenous inte-
grins in these cells were sufficient for this function.
Accordingly, we reasoned that the participation of these
endogenous integrins might become apparent if their func-
tion was specifically impaired. The b3 mutation Ser753Pro
abrogates agonist-induced aIIbb3 function in platelets
and, when expressed in CHO cells, reduces b3-mediated
cell spreading (Chen et al., 1992, 1994b). Therefore,
we microinjected REF52 cells with pseudo-phosphory-
lated pleckstrin along with either wild-type aIIbb3 or
aIIbb3 Ser753Pro. As shown by the quantitation in Fig. 3
and photomicrographs in Fig. 5, microinjecting aIIbb3
Ser753Pro into REF52 cells abrogated cell spreading in-
duced by pleckstrin, whereas wild-type aIIbb3 had no ef-
fect (P , 0.0001 and P 5 0.32, respectively). Moreover,
there was no difference in footprint size between REF52
cells expressing pseudo-phosphorylated pleckstrin along
with either wild-type aIIbb3 or aIIbb3 Ser753Pro when
plated on fibronectin-coated surfaces (P 5 0.30). Thus,
these experiments suggest that integrins modulate the ef-
fect of pleckstrin in REF52 cells and that b3 Ser753Pro
functions as a dominant negative inhibitor in this regard.
We found that, like our results using REF52 cells plated
on fibrinogen, expression of wild-type aIIbb3 in CHO
cells does not influence pleckstrin-mediated cell spread-
ing, whereas spreading was abrogated by aIIbb3 S752P.
Moreover, b3 S752P alone abrogated the pleckstrin effect
(Fig. 6, A and B). Because b3 is not expressed on the cell
surface unless it is coupled to an a-subunit, it is likely that
b3 S752P is associated with the widely expressed av inte-
grin subunit (Kolodziej et al., 1991). This implies that b3
Ser753Pro inhibits pleckstrin-mediated spreading by dis-
rupting the function of an endogenous b3-containing inte-
grin (such as avb3).
We next tested whether “outside-in” integrin signaling
was critical for pleckstrin-mediated cell spreading by mea-
suring the effect of chimeric proteins composed of the ex-
tracellular and transmembrane portions of Tac fused to
the cytoplasmic tail of a or b integrin subunits on pleck-
strin-mediated cell spreading. Tac–integrin fusion proteins
have previously been shown to disrupt integrin function,
presumably by competing for intracellular factors that as-
sociate with integrin cytoplasmic tails (LaFlamme et al.,
1992; Chen et al., 1994a). As shown in Fig. 6 C, Tac–b3
functioned as a dominant-negative inhibitor of pleckstrin
spreading, whereas Tac–aIIb and Tac–b3 S752P had no ef-
fect. Thus, these experiments demonstrate that overex-
pression of the wild-type b3 tail alone specifically inhibits
the ability of pleckstrin to induce cell spreading, suggest-
ing that it specifically impairs the ability of endogenous b3
integrins to support pleckstrin function. b3 S752P, on the
other hand, had no effect because S752P is an inactivating
mutation.
Discussion
We reported previously that expressed pleckstrin will bind
to plasma membranes and induce lamellipodia and actin
reorganization (Ma et al., 1997; Ma and Abrams, 1999).
Figure 3. Quantification of
effect of pleckstrin, aIIbb3,
or variants on REF52 cell
spreading on fibrinogen or fi-
bronectin. Quiescent REF52
cells, plated on fibronectin or
fibrinogen, were microin-
jected with plasmids that di-
rect the expression of GFP
alone, wild-type aIIbb3
alone, nonphosphorylatable
pleckstrin alone, pseudo-
phosphorylated pleckstrin
alone, wild-type aIIbb3 with
nonphosphorylatable pleck-
strin, wild-type aIIbb3 with
pseudo-phosphorylated pleck-
strin, or aIIbb3 Ser753Pro
with pseudo-phosphorylated
pleckstrin. Images were cap-
tured and cell footprint size
was quantified using Im-
ageIQ software. Pleckstrin in-
duces cell spreading on fibrin-
ogen, but not fibronectin, and
this effect is inhibited by co-
expression of aIIbb3 Ser753
Pro. Shown is the mean 6
SEM from three experiments.Roll et al. Pleckstrin and Cell Spreading 1465
We have now found that expressed and phosphorylated
pleckstrin also induces cell spreading through an integrin-
dependent pathway and that this effect is adhesion sub-
strate–specific.
The observation that pleckstrin-induced cell spreading
is inhibited by the dominant-negative aIIbb3 Ser753Pro
mutant implies that pleckstrin cooperates with integrins to
mediate cell signaling. Most integrins respond to agonist-
stimulated signals (“inside-out” signaling) that regulate
their ability to bind to extracellular matrix proteins, where
binding to the matrix itself initiates signals (“outside-in”
signaling) that increases the cytosolic concentration of cal-
cium, causes the phosphorylation of a number of signaling
proteins, and induces the reorganization of the cytoskele-
ton (Shattil, 1999; Giancotti and Ruoslahti, 1999). Our
data place pleckstrin either upstream of aIIbb3, where it
induces the integrin to bind its ligand, or downstream of
aIIbb3, where it enhances integrin-initiated cell spreading.
Given current information, either of these possibilities is
equally likely to contribute to this phenomenon.
It is not currently known how an adapter protein such as
pleckstrin, with no apparent enzymatic activity, could in-
duce cell spreading. One possibility is that pleckstrin di-
rectly interacts with and alters the cytoplasmic tail of
aIIbb3. However, we have not been able to detect pleck-
strin in immunoprecipitates of aIIbb3 or vice versa
(Abrams, C.S., and L. Brass, unpublished observation).
An alternative explanation is that pleckstrin binds and se-
questers a critical phospholipid cofactor required for inte-
grin signaling. For example, Kolanus et al. (1996) reported
that the PH domain–containing protein, cytoadhesin, is
able to activate aLb2 when it is overexpressed in Jurkat
cells. Finally, it is possible that the effect of pleckstrin on
the cytoskeleton is downstream of integrins, potentially
via a small GTP-binding protein of the Rho family or an
actin capping protein (Janmey, 1998). Consistent with this
possibility, Miranti et al. (1998) placed activation of Rac
downstream of aIIbb3.
Many integrins interact with a variety of extracellu-
lar matrix proteins. We found that pleckstrin promotes
spreading on fibrinogen, but not on fibronectin. This ob-
servation, coupled with the finding that the b3 mutant
Ser753Pro inhibits pleckstrin-induced spreading, suggests
that the pleckstrin effect may be specific for b3 integrins
and their ligands. This would also include a possible pleck-
strin effect on the endogenously expressed avb3 integrins
found in fibroblasts.
Our data also indicates an important role for integrin b
subunits signaling effectors. Chen et al. (1994a) have dem-
onstrated that overexpressing a chimeric protein consist-
ing of the extracellular and transmembrane domains of
human Tac fused to the cytoplasmic domain of b3 had a
dominant-negative effect on integrin-dependent signaling.
We have also found that coexpression of Tac-b3, but not
Tac-aIIb or Tac-b3 S752P, inhibited pleckstrin-mediated
spreading. This suggests that direct binding of integrin cy-
toplasmic tails to associated proteins is critical for this phe-
nomenon.
The identity of the cytoplasmic protein that associates
with b-integrin subunit to cooperate with pleckstrin in me-
diating cell spreading is unclear. Numerous candidate pro-
teins that directly or indirectly associate with b-chain cyto-
plasmic tails include: paxcillin, talin, vinculin, Src, FAK,
b3-endonexin, a-actinin, ILK, ICAP-1, filamin, cytohesin-1,
p27BBP, and rack 1 (Shattil et al., 1998; Giancotti and Ruo-
Figure 4. Pleckstrin-induced REF52 cell spreading is matrix de-
pendent. Quiescent REF52 cells plated on fibrinogen (A–C) or
fibronectin (D–F) were microinjected with plasmids that direct
the expression of wild-type aIIbb3 alone (A and D), HA–
pseudo-phosphorylated pleckstrin alone (B and E), or HA–
pseudo-phosphorylated pleckstrin with wild-type aIIbb3 (C and
F). Cells were stained both with anti-HA, to detect pleckstrin,
and anti-b3, to detect aIIbb3. Shown are anti-b3 (A and D) and
anti-HA staining (B, C, E, and F), as visualized by indirect immu-
nofluorescence. This figure demonstrates that pleckstrin induces
cell spreading on fibrinogen, but not on fibronectin. Expression
of wild-type aIIbb3 did not alter pleckstrin-induced spreading.
Original magnifications, 320.
Figure 5. aIIbb3 Ser753Pro blocks pleckstrin-induced REF52
cell spreading on fibrinogen. Quiescent REF52 cells were plated
on fibrinogen (A and B) or fibronectin (C and D), and then mi-
croinjected with plasmids that direct the coexpression of HA–
pseudo-phosphorylated pleckstrin and either wild-type aIIbb3
(A and C) or aIIbb3 Ser753Pro (B and D). Cells were stained
both with anti-HA, to detect pleckstrin, and anti-b3, to detect
aIIbb3. Shown is anti-HA staining as visualized by indirect im-
munofluorescence. Pseudo-phosphorylated pleckstrin and wild-
type aIIbb3 induces REF52 cell spreading on fibrinogen, but not
on fibronectin. This pleckstrin-induced spreading was inhibited
by aIIbb3 Ser753Pro. Original magnifications, 320.The Journal of Cell Biology, Volume 150, 2000 1466
slahti, 1999). Many of these proteins have been postulated
to assist the anchoring of integrins to the actin cytoskele-
ton. Whether any of these proteins are critical for pleck-
strin-induced cell spreading is an area of active interest.
Our data suggest that overexpressed pleckstrin contrib-
utes to the process of integrin-mediated cytoskeletal
change. An important issue that has not yet been deter-
mined is whether pleckstrin plays a similar role in cells in
which it is normally expressed. Approximately 1% of total
cellular protein in platelets and leukocytes is pleckstrin
and its rapid phosphorylation is a hallmark of platelet acti-
vation. Accordingly, the agonist-stimulated behavior of
platelets and leukocytes from pleckstrin-deficient mice
may provide the most facile, and only readily available,
way to verify pleckstrin function in blood cells.
These studies were supported in part by funds from the National Institutes
of Health (grant Nos. P50 HL54500 and P01 HL40387).
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Figure 6. Quantification of effect of pleckstrin and
integrin mutants on CHO cell spreading. CHO cells
were transiently transfected with plasmids that di-
rect the expression of GFP or wild-type pleckstrin
alone (A), or wild-type pleckstrin along with either
aIIb & b3 Ser753Pro or b3 Ser753Pro (B), or wild
type pleckstrin along with either Tac-aIIb, Tac-b3,
or Tac-b3 Ser753Pro (C). Images were captured and
cell footprint size was quantified using ImageIQ
software. Pleckstrin-induced cell spreading was in-
hibited by co-expression of aIIbb3 Ser753Pro, b3
Ser753Pro, or Tac-b3. In contrast, Tac-aIIb or Tac-
b3 Ser753Pro had little effect. Shown is the mean 6
SEM from three experiments.